Local Covid Anti-Vaxxers vs Studies Spammers

[pugboy]

they might need to start taking them tablets soon with the next wave coming

[adnj]

At what stage were they given it? When they deteriorated or early on as symptoms developed?

If you do become ill, take fluoxetine or fluvoxamine instead.

Both are cheap. Both have been show likely effectiveness. Both are widely available. Both are generic. Both have been around for about 30 years.

[meccalli]

Another study testing the effectiveness of a curing agent on epoxy without resin lol. The pathophysiological rationale for use of ivermectin is within the first 7 days of infection as ionophore that conveys zinc intracellularly to block the SARS-CoV-2 RNA-dependent RNA polymerase, which is the core enzyme of the virus replication. Other ionophores that were used by early treatment practitioners were quercetin, HCQ, and thymoquinone, dithymoquinone, or thymohydroquinone containing extracts such as from nigella sativa.
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973827/

[adnj]

Another study testing the effectiveness of a curing agent on epoxy without resin lol. The pathophysiological rationale for use of ivermectin is within the first 7 days of infection as ionophore that conveys zinc intracellularly to block the SARS-CoV-2 RNA-dependent RNA polymerase, which is the core enzyme of the virus replication. Other ionophores that were used by early treatment practitioners were quercetin, HCQ, and thymoquinone, dithymoquinone, or thymohydroquinone containing extracts such as from nigella sativa.
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2973827/

Time for you to get off the hammock and run your study. Zinc may help - but there is nothing that has been published that has been able to show clinical usefulness.

You do have background and funding sufficient to run a study, don't you?


A Case-Control Study for the Effectiveness of Oral Zinc in the Prevention and Mitigation of COVID-19

13 December 2021

Discussion: The findings from our study suggest that zinc supplementation in all three doses (10, 25, and 50 mg) may be an effective prophylaxis of symptomatic COVID-19 and may mitigate the severity of COVID-19 infection.

Conclusion: Zinc is a relatively inexpensive mineral nutrient that is an effective prophylactic agent to prevent and mitigate the potentially deadly symptomatic SARS-CoV-2 infection.

https://www.frontiersin.org/articles/10 ... 56707/full

[meccalli]

ou do have background and funding sufficient to run a study, don't you?

It's ironic how it was the early treatment proponents who actually gave a damn about it, Misinformation spreader Steve kirsch started and funded the Covid-19 Early Treatment Fund (CETF) that identified not only ivermectin for early treatment but fluvoxamine as useful as the disease progressed.
https://www.prnewswire.com/news-release ... 42164.html

[adnj]

ou do have background and funding sufficient to run a study, don't you?

It's ironic how it was the early treatment proponents who actually gave a damn about it, Misinformation spreader Steve kirsch started and funded the Covid-19 Early Treatment Fund (CETF) that identified not only ivermectin for early treatment but fluvoxamine as useful as the disease progressed.
https://www.prnewswire.com/news-release ... 42164.html

I am not opposed to the use of oral zinc as a prophylactic for COVID. It has been shown to work for other coronaviruses.

I am opposed to presenting personal opinion as fact and anecdotal evidence as proof. Run a study. Until then, it's just talk.

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants

November 15, 2021

Conclusions and Relevance  These results support evidence that SSRIs may be associated with reduced severity of COVID-19 reflected in the reduced RR of mortality. Further research and randomized clinical trials are needed to elucidate the effect of SSRIs generally, or more specifically of fluoxetine and fluvoxamine, on the severity of COVID-19 outcomes.

https://jamanetwork.com/journals/jamane ... le/2786136

[matr1x]

The decrease in numbers is purely because they are testing less

[timelapse]

The decrease in numbers is purely because they are testing less

This I agree with.I am sure a lot of people who tested positive for a home test did not report it

[matr1x]

At health centers they not testing you unless you sick. Let that sink in

[hover11]

Empty streets are seen in China’s biggest city, Shanghai, amid restrictions stemming from the country’s worst COVID-19 outbreak in two years. https://abcn.ws/36iY41G

[hover11]

Xi jinping wouldn't destroy his economy like this over a mild virus but carry on ....everything back to normal

[adnj]

Evidence grows that vaccines lower the risk of getting long COVID

March 24, 2022

The chance of even a mild case of COVID-19 turning into a long-term, debilitating medical condition is one of the greatest fears of Americans trying to navigate the pandemic, which is again taking a turn as new data show the BA.2 subvariant is taking hold in the U.S.

Unfortunately, the only sure way to avoid long COVID is not to catch the virus in the first place.

But there is now a growing body of research that's offering at least some reassurance for those who do end up getting infected — being fully vaccinated seems to substantially cut the risk of later developing the persistent symptoms that characterize long COVID.

While many of the findings are still preliminary, the handful of studies that have emerged in the past half year are telling a relatively consistent story.

"It may not eradicate the symptoms of long COVID, but the protective effect seems to be very strong," says epidemiology professor Michael Edelstein, of Bar-Ilan University in Israel, who's studying long COVID.

Edelstein's study was one of those included in a recent analysis of the evidence on long COVID and vaccination done by the UK Health Security Agency. That review found vaccinated people tend to have lower rates of long COVID after an infection than those who are unvaccinated.

There's a running list of theories about why people get long COVID. Permanent tissue damage from the infection, injury to blood vessels and the development of microclots, a lingering viral reservoir in parts of the body, or an autoimmune condition are some of the ideas being explored in the research.

But even without a clear sense of what's exactly driving long COVID, there's good reason to believe that vaccines would help guard against the condition, says Dr. Steven Deeks, a professor of medicine at the University of California, San Francisco.

There's overwhelming evidence that someone who's vaccinated has less virus in their body during an infection, he says, "so it would make great sense that the amount of virus-related complications over time would also be lower."

https://www.npr.org/sections/health-sho ... d-vaccines

[adnj]

UK Covid infections climb by a million in a week

Swab tests suggest about one in every 16 people is infected, as the contagious Omicron variant BA.2 continues to spread.



https://www.bbc.com/news/health-60872687

[Mmoney607]

UK Covid infections climb by a million in a week

Swab tests suggest about one in every 16 people is infected, as the contagious Omicron variant BA.2 continues to spread.



https://www.bbc.com/news/health-60872687

Oh boy, you will be crying when massa gives us our freedom later today

[De Dragon]

Evidence grows that vaccines lower the risk of getting long COVID

March 24, 2022

The chance of even a mild case of COVID-19 turning into a long-term, debilitating medical condition is one of the greatest fears of Americans trying to navigate the pandemic, which is again taking a turn as new data show the BA.2 subvariant is taking hold in the U.S.

Unfortunately, the only sure way to avoid long COVID is not to catch the virus in the first place.

But there is now a growing body of research that's offering at least some reassurance for those who do end up getting infected — being fully vaccinated seems to substantially cut the risk of later developing the persistent symptoms that characterize long COVID.

While many of the findings are still preliminary, the handful of studies that have emerged in the past half year are telling a relatively consistent story.

"It may not eradicate the symptoms of long COVID, but the protective effect seems to be very strong," says epidemiology professor Michael Edelstein, of Bar-Ilan University in Israel, who's studying long COVID.

Edelstein's study was one of those included in a recent analysis of the evidence on long COVID and vaccination done by the UK Health Security Agency. That review found vaccinated people tend to have lower rates of long COVID after an infection than those who are unvaccinated.

There's a running list of theories about why people get long COVID. Permanent tissue damage from the infection, injury to blood vessels and the development of microclots, a lingering viral reservoir in parts of the body, or an autoimmune condition are some of the ideas being explored in the research.

But even without a clear sense of what's exactly driving long COVID, there's good reason to believe that vaccines would help guard against the condition, says Dr. Steven Deeks, a professor of medicine at the University of California, San Francisco.

There's overwhelming evidence that someone who's vaccinated has less virus in their body during an infection, he says, "so it would make great sense that the amount of virus-related complications over time would also be lower."

https://www.npr.org/sections/health-sho ... d-vaccines

Lee dem lazy fackers. Somebody go do eet fuh dem

[hover11]

BREAKING: FDA authorizes second round of booster shots for everyone over the age of 50—kicking off the regulatory process for shots to likely be available in pharmacies sometime this week. https://abcn.ws/3uCrRdZ


Roll up those sleeves

[redmanjp]

BREAKING: FDA authorizes second round of booster shots for everyone over the age of 50—kicking off the regulatory process for shots to likely be available in pharmacies sometime this week. https://abcn.ws/3uCrRdZ


Roll up those sleeves

over 50. yuh eh want yuh fadder who have pressure and sugar to get it?

[Mmoney607]

[wing]

BREAKING: FDA authorizes second round of booster shots for everyone over the age of 50—kicking off the regulatory process for shots to likely be available in pharmacies sometime this week. https://abcn.ws/3uCrRdZ


Roll up those sleeves

over 50. yuh eh want yuh fadder who have pressure and sugar to get it?

Red, I blame you and adnj and st7 and others who obviously fall for the trolls in here and encourage their antivax, Qanon, conspiracy theory, anti science etc. Just ignore them, they are beyond convincing.

[adnj]

[stev]

any estimated time until the unvaccinated die out? about 6 years?

can't remember the last study I read...probably late 2020 estimation...any updates?

[ed360123]

any estimated time until the unvaccinated die out? about 6 years?

can't remember the last study I read...probably late 2020 estimation...any updates?

Most will die out in 70 years

[redmanjp]

3000 of them already ded. they lucky omicron is a lil more merciful.

[paid_influencer]

::sneeze::

sharan dust bad this week

[adnj]

Ivermectin study finds drug does not reduce Covid hospitalisation rate

Drug was widely touted as a cure for the disease despite little evidence of its efficacy

One of the largest studies into the use of ivermectin to treat Covid-19 has found the controversial drug does not reduce the rate at which patients require hospitalisation for serious illness.

The study was co-led by Irish-born scientist Prof Ed Mills, who is based in Canada, and funded by the billionaire Collison brothers, founders of the digital payment firm Stripe.

The research, part of the largest placebo-controlled trial for Covid-19 treatments in the world, has so far evaluated 11 low-cost drugs and found two – fluvoxamine and peginterferon lambda – effective.

The evaluation of ivermectin involved 3,515 Covid patients in Brazil, who were given the drug, a placebo or another intervention.

Overall, 100 patients in the ivermectin group had to be hospitalised or had to go to an emergency department, compared with 111 in the placebo group.

“Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to the progression of Covid-19 or prolonged emergency department observation among outpatients with an early diagnosis of Covid-19,” the researchers concluded.

https://www.irishtimes.com/news/health/ ... -1.4840374

Effect of Early Treatment with Ivermectin among Patients with Covid-19

Abstract

BACKGROUND

The efficacy of ivermectin in preventing hospitalization or extended observation in an emergency setting among outpatients with acutely symptomatic coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unclear.

METHODS

We conducted a double-blind, randomized, placebo-controlled, adaptive platform trial involving symptomatic SARS-CoV-2–positive adults recruited from 12 public health clinics in Brazil. Patients who had had symptoms of Covid-19 for up to 7 days and had at least one risk factor for disease progression were randomly assigned to receive ivermectin (400 μg per kilogram of body weight) once daily for 3 days or placebo. (The trial also involved other interventions that are not reported here.) The primary composite outcome was hospitalization due to Covid-19 within 28 days after randomization or an emergency department visit due to clinical worsening of Covid-19 (defined as the participant remaining under observation for >6 hours) within 28 days after randomization.

RESULTS

A total of 3515 patients were randomly assigned to receive ivermectin (679 patients), placebo (679), or another intervention (2157). Overall, 100 patients (14.7%) in the ivermectin group had a primary-outcome event, as compared with 111 (16.3%) in the placebo group (relative risk, 0.90; 95% Bayesian credible interval, 0.70 to 1.16). Of the 211 primary-outcome events, 171 (81.0%) were hospital admissions. Findings were similar to the primary analysis in a modified intention-to-treat analysis that included only patients who received at least one dose of ivermectin or placebo (relative risk, 0.89; 95% Bayesian credible interval, 0.69 to 1.15) and in a per-protocol analysis that included only patients who reported 100% adherence to the assigned regimen (relative risk, 0.94; 95% Bayesian credible interval, 0.67 to 1.35). There were no significant effects of ivermectin use on secondary outcomes or adverse events.

CONCLUSIONS

Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19. (Funded by FastGrants and the Rainwater Charitable Foundation; TOGETHER ClinicalTrials.gov number, NCT04727424. opens in new tab.)

https://www.nejm.org/doi/full/10.1056/NEJMoa2115869

[timelapse]

That study not real ADNJ.In before Hover.lol

[hover11]

As if the jabs and circuit-breaker lockdowns weren’t enough but no..there’ll still be those that roll up their sleeves for a 4th, 5th and 6th jab even after having the virus they’re jabbed against. Honestly I cannot believe what I’m witnessing

[st7]

That study not real ADNJ.In before Hover.lol

lolllll

[timelapse]

As if the jabs and circuit-breaker lockdowns weren’t enough but no..there’ll still be those that roll up their sleeves for a 4th, 5th and 6th jab even after having the virus they’re jabbed against. Honestly I cannot believe what I’m witnessing

Take yuh Ivermectin and go in yuh bed nah

[adnj]

According to the US CDC, 21× as many unvaccinated people died in the US in January 2022 from COVID when compared to people who vaccinated and boosted.